Fukoku Mutual Life Insurance’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $871K | Buy |
1,753
+356
| +25% | +$158K | 0.05% | 83 |
|
|
2026
Q1 | $624K | Hold |
1,397
| – | – | 0.04% | 82 |
|
|
2025
Q4 | $633K | Sell |
1,397
-192
| -12% | -$82.8K | 0.04% | 93 |
|
|
2025
Q3 | $622K | Hold |
1,589
| – | – | 0.04% | 96 |
|
|
2025
Q2 | $707K | Sell |
1,589
-226
| -12% | -$104K | 0.05% | 93 |
|
|
2025
Q1 | $880K | Sell |
1,815
-40
| -2% | -$18.6K | 0.07% | 71 |
|
|
2024
Q4 | $747K | Hold |
1,855
| – | – | 0.05% | 84 |
|
|
2024
Q3 | $863K | Hold |
1,855
| – | – | 0.06% | 77 |
|
|
2024
Q2 | $869K | Sell |
1,855
-166
| -8% | -$72.1K | 0.07% | 73 |
|
|
2024
Q1 | $845K | Sell |
2,021
-119
| -6% | -$50.3K | 0.07% | 71 |
|
|
2023
Q4 | $871K | Sell |
2,140
-500
| -19% | -$185K | 0.07% | 79 |
|
|
2023
Q3 | $918K | Buy |
2,640
+500
| +23% | +$175K | 0.08% | 66 |
|
|
2023
Q2 | $753K | Hold |
2,140
| – | – | 0.07% | 75 |
|
|
2023
Q1 | $674K | Sell |
2,140
-1,000
| -32% | -$300K | 0.06% | 81 |
|
|
2022
Q4 | $907K | Buy |
3,140
+1,720
| +121% | +$524K | 0.08% | 73 |
|
|
2022
Q3 | $411K | Hold |
1,420
| – | – | 0.04% | 138 |
|
|
2022
Q2 | $400K | Sell |
1,420
-30
| -2% | -$8.03K | 0.03% | 147 |
|
|
2022
Q1 | $378K | Sell |
1,450
-100
| -6% | -$23.7K | 0.03% | 184 |
|
|
2021
Q4 | $340K | Buy |
1,550
+60
| +4% | +$11.7K | 0.03% | 217 |
|
|
2021
Q3 | $270K | Sell |
1,490
-210
| -12% | -$41K | 0.02% | 251 |
|
|
2021
Q2 | $343K | Hold |
1,700
| – | – | 0.03% | 185 |
|
|
2021
Q1 | $365K | Hold |
1,700
| – | – | 0.04% | 146 |
|
|
2020
Q4 | $402K | Hold |
1,700
| – | – | 0.04% | 136 |
|
|
2020
Q3 | $463K | Buy |
1,700
+200
| +13% | +$55.2K | 0.05% | 120 |
|
|
2020
Q2 | $435K | Hold |
1,500
| – | – | 0.05% | 118 |
|
|
2020
Q1 | $357K | Hold |
1,500
| – | – | 0.05% | 112 |
|
|
2019
Q4 | $328K | Buy |
1,500
+200
| +15% | +$40.5K | 0.04% | 177 |
|
|
2019
Q3 | $220K | Hold |
1,300
| – | – | 0.03% | 195 |
|
|
2019
Q2 | $238K | Hold |
1,300
| – | – | 0.03% | 176 |
|
|
2019
Q1 | $239K | Sell |
1,300
-100
| -7% | -$18.5K | 0.03% | 165 |
|
|
2018
Q4 | $232K | Buy |
1,400
+200
| +17% | +$34.7K | 0.03% | 170 |
|
|
2018
Q3 | $231K | Sell |
1,200
-200
| -14% | -$35.6K | 0.03% | 193 |
|
|
2018
Q2 | $238K | Hold |
1,400
| – | – | 0.03% | 174 |
|
|
2018
Q1 | $228K | Hold |
1,400
| – | – | 0.04% | 173 |
|
|
2017
Q4 | $210K | Hold |
1,400
| – | – | 0.03% | 197 |
|
|
2017
Q3 | $213K | Sell |
1,400
-100
| -7% | -$15.1K | 0.03% | 190 |
|
|
2017
Q2 | $193K | Hold |
1,500
| – | – | 0.03% | 210 |
|
|
2017
Q1 | $164K | Buy |
1,500
+100
| +7% | +$8.8K | 0.03% | 209 |
|
|
2016
Q4 | $103K | Buy |
1,400
+100
| +8% | +$8.14K | 0.02% | 252 |
|
|
2016
Q3 | $113K | Hold |
1,300
| – | – | 0.02% | 241 |
|
|
2016
Q2 | $112K | Hold |
1,300
| – | – | 0.02% | 246 |
|
|
2016
Q1 | $103K | Buy |
1,300
+200
| +18% | +$18.1K | 0.02% | 252 |
|
|
2015
Q4 | $138K | Hold |
1,100
| – | – | 0.02% | 248 |
|
|
2015
Q3 | $115K | Buy |
1,100
+500
| +83% | +$64.2K | 0.02% | 258 |
|
|
2015
Q2 | $74K | Hold |
600
| – | – | 0.01% | 300 |
|
|
2015
Q1 | $71K | Buy |
600
+200
| +50% | +$24K | 0.01% | 298 |
|
|
2014
Q4 | $48K | Buy |
+400
| New | +$45.1K | 0.01% | 309 |
|
Other funds holding VRTX
DC
BHIA
CTB
AAIS
Fukoku Mutual Life Insurance's VRTX Position: Q2 2026 in Review
Fukoku Mutual Life Insurance increased its Vertex Pharmaceuticals (VRTX) stake by 25% in Q2 2026, buying an estimated $158K and bringing the position to 1,753 shares worth $871K. The position accounts for 0.05% of the portfolio, ranked #83.
Fukoku Mutual Life Insurance first reported a position in VRTX in Q4 2014 and has held it in 47 quarters since. The position peaked at $918K in Q3 2023. 484 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Fukoku Mutual Life Insurance held 1,753 shares of Vertex Pharmaceuticals worth $871K as of Q2 2026.
- Fukoku Mutual Life Insurance bought 356 Vertex Pharmaceuticals shares in Q2 2026, an estimated $158K.
- Vertex Pharmaceuticals made up 0.05% of Fukoku Mutual Life Insurance's portfolio in Q2 2026, its #83 holding.
- Fukoku Mutual Life Insurance first reported a position in Vertex Pharmaceuticals in Q4 2014 and has held it in 47 quarters since.
- Fukoku Mutual Life Insurance's Vertex Pharmaceuticals position peaked at $918K in Q3 2023.
- 484 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Fukoku Mutual Life Insurance's 13F filing for Q2 2026, filed 24 Jul 2026.